AG Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the company’s pricing of insulin products. Under the settlement, Mainers who are uninsured or who have commercial health insurance will be eligible to purchase monthly supplies of Sanofi insulin products through 2029 for $35 cash. The products covered include Admelog, Lantus, Toujeo, Apidra and any biosimilar of those products that Sanofi markets in the U.S.  “Insulin is life-sustaining medication and far too many Mainers struggle to afford it,” said Attorney General Frey. “My Office will continue to closely monitor drug pricing and take action to protect consumers to ensure access to these essential medications.” 

Office of the Maine AG: News & Reports